Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 868750 | 4.455 |
09:34 ET | 49236 | 4.4312 |
09:36 ET | 32016 | 4.4101 |
09:38 ET | 100305 | 4.425 |
09:39 ET | 24457 | 4.435 |
09:41 ET | 6700 | 4.445 |
09:43 ET | 17608 | 4.455 |
09:45 ET | 18262 | 4.42 |
09:48 ET | 10244 | 4.44 |
09:50 ET | 13941 | 4.445 |
09:52 ET | 17235 | 4.425 |
09:54 ET | 91417 | 4.4601 |
09:56 ET | 28453 | 4.485 |
09:57 ET | 4686 | 4.485 |
09:59 ET | 26950 | 4.475 |
10:01 ET | 9643 | 4.485 |
10:03 ET | 43648 | 4.505 |
10:06 ET | 15973 | 4.485 |
10:08 ET | 15163 | 4.485 |
10:10 ET | 16545 | 4.495 |
10:12 ET | 19299 | 4.5 |
10:14 ET | 8144 | 4.505 |
10:15 ET | 8659 | 4.51 |
10:17 ET | 97045 | 4.535 |
10:19 ET | 28134 | 4.55 |
10:21 ET | 40692 | 4.53 |
10:24 ET | 7007 | 4.53 |
10:26 ET | 4076 | 4.54 |
10:28 ET | 23044 | 4.525 |
10:30 ET | 31584 | 4.526 |
10:32 ET | 17210 | 4.52 |
10:33 ET | 4729 | 4.525 |
10:35 ET | 102925 | 4.495 |
10:37 ET | 29920 | 4.48 |
10:39 ET | 14649 | 4.46 |
10:42 ET | 14876 | 4.455 |
10:44 ET | 24425 | 4.47 |
10:46 ET | 12290 | 4.475 |
10:48 ET | 7653 | 4.475 |
10:50 ET | 19476 | 4.48 |
10:51 ET | 14763 | 4.475 |
10:53 ET | 3484 | 4.475 |
10:55 ET | 35007 | 4.4751 |
10:57 ET | 3612 | 4.4775 |
11:00 ET | 72791 | 4.475 |
11:02 ET | 44350 | 4.495 |
11:04 ET | 16005 | 4.495 |
11:06 ET | 59381 | 4.495 |
11:08 ET | 3800 | 4.495 |
11:09 ET | 1000 | 4.4975 |
11:11 ET | 30745 | 4.485 |
11:13 ET | 14119 | 4.485 |
11:15 ET | 13383 | 4.485 |
11:18 ET | 15224 | 4.5 |
11:20 ET | 5100 | 4.5 |
11:22 ET | 13819 | 4.505 |
11:24 ET | 5212 | 4.5075 |
11:26 ET | 4350 | 4.5075 |
11:27 ET | 9746 | 4.495 |
11:29 ET | 4872 | 4.49 |
11:31 ET | 13375 | 4.485 |
11:33 ET | 11119 | 4.4975 |
11:36 ET | 3401 | 4.495 |
11:38 ET | 8684 | 4.49 |
11:40 ET | 10981 | 4.485 |
11:42 ET | 22152 | 4.485 |
11:44 ET | 10907 | 4.475 |
11:45 ET | 4800 | 4.4775 |
11:47 ET | 38555 | 4.485 |
11:49 ET | 3600 | 4.485 |
11:51 ET | 2400 | 4.4875 |
11:54 ET | 9255 | 4.4865 |
11:56 ET | 19573 | 4.495 |
11:58 ET | 12486 | 4.495 |
12:00 ET | 6608 | 4.495 |
12:02 ET | 10768 | 4.495 |
12:03 ET | 31688 | 4.505 |
12:05 ET | 14025 | 4.52 |
12:07 ET | 24623 | 4.515 |
12:09 ET | 8357 | 4.515 |
12:12 ET | 7369 | 4.52 |
12:14 ET | 79460 | 4.505 |
12:16 ET | 13600 | 4.49 |
12:18 ET | 3500 | 4.49 |
12:20 ET | 17626 | 4.485 |
12:21 ET | 6744 | 4.485 |
12:23 ET | 2377 | 4.48 |
12:25 ET | 7585 | 4.485 |
12:27 ET | 31234 | 4.48 |
12:30 ET | 19520 | 4.495 |
12:32 ET | 24130 | 4.505 |
12:34 ET | 11356 | 4.505 |
12:36 ET | 14601 | 4.505 |
12:38 ET | 4803 | 4.51 |
12:39 ET | 23442 | 4.505 |
12:41 ET | 4632 | 4.515 |
12:43 ET | 4900 | 4.515 |
12:45 ET | 7914 | 4.515 |
12:48 ET | 6488 | 4.51 |
12:50 ET | 19439 | 4.495 |
12:52 ET | 16100 | 4.49 |
12:54 ET | 12800 | 4.49 |
12:56 ET | 3374 | 4.49 |
12:57 ET | 21852 | 4.49 |
12:59 ET | 18537 | 4.48 |
01:01 ET | 2824 | 4.48 |
01:03 ET | 2800 | 4.485 |
01:06 ET | 5100 | 4.485 |
01:08 ET | 40020 | 4.49 |
01:10 ET | 4600 | 4.485 |
01:12 ET | 8471 | 4.475 |
01:14 ET | 3017 | 4.4788 |
01:15 ET | 1140 | 4.47 |
01:17 ET | 20984 | 4.47 |
01:19 ET | 25387 | 4.475 |
01:21 ET | 53211 | 4.485 |
01:24 ET | 16690 | 4.49 |
01:26 ET | 14985 | 4.495 |
01:28 ET | 11200 | 4.5 |
01:30 ET | 21123 | 4.49 |
01:32 ET | 14900 | 4.49 |
01:33 ET | 1463 | 4.5 |
01:35 ET | 26097 | 4.5 |
01:37 ET | 8821 | 4.5 |
01:39 ET | 11041 | 4.52 |
01:42 ET | 10000 | 4.53 |
01:44 ET | 9282 | 4.53 |
01:46 ET | 13731 | 4.54 |
01:48 ET | 238448 | 4.55 |
01:50 ET | 31049 | 4.575 |
01:51 ET | 13522 | 4.58 |
01:53 ET | 17081 | 4.59 |
01:55 ET | 8513 | 4.59 |
01:57 ET | 12751 | 4.59 |
02:00 ET | 95102 | 4.6 |
02:02 ET | 87849 | 4.6 |
02:04 ET | 6389 | 4.6 |
02:06 ET | 52912 | 4.57 |
02:08 ET | 4999 | 4.58 |
02:09 ET | 7059 | 4.575 |
02:11 ET | 46442 | 4.58 |
02:13 ET | 6641 | 4.585 |
02:15 ET | 21337 | 4.589 |
02:18 ET | 26519 | 4.6 |
02:20 ET | 20512 | 4.585 |
02:22 ET | 15670 | 4.595 |
02:24 ET | 14231 | 4.585 |
02:26 ET | 14363 | 4.6 |
02:27 ET | 13100 | 4.6 |
02:29 ET | 85226 | 4.575 |
02:31 ET | 31131 | 4.555 |
02:33 ET | 20065 | 4.525 |
02:36 ET | 58342 | 4.52 |
02:38 ET | 23749 | 4.51 |
02:40 ET | 31014 | 4.51 |
02:42 ET | 28761 | 4.51 |
02:44 ET | 24732 | 4.505 |
02:45 ET | 22875 | 4.5103 |
02:47 ET | 16402 | 4.52 |
02:49 ET | 23888 | 4.5 |
02:51 ET | 6373 | 4.5 |
02:54 ET | 35820 | 4.495 |
02:56 ET | 6966 | 4.495 |
02:58 ET | 8480 | 4.495 |
03:00 ET | 36699 | 4.49 |
03:02 ET | 8087 | 4.485 |
03:03 ET | 39777 | 4.5 |
03:05 ET | 9374 | 4.495 |
03:07 ET | 44726 | 4.5 |
03:09 ET | 16886 | 4.51 |
03:12 ET | 22037 | 4.505 |
03:14 ET | 24053 | 4.505 |
03:16 ET | 19305 | 4.505 |
03:18 ET | 58721 | 4.505 |
03:20 ET | 21297 | 4.51 |
03:21 ET | 24263 | 4.505 |
03:23 ET | 6322 | 4.505 |
03:25 ET | 8752 | 4.5011 |
03:27 ET | 91137 | 4.49 |
03:30 ET | 29395 | 4.5089 |
03:32 ET | 58025 | 4.49 |
03:34 ET | 24414 | 4.49 |
03:36 ET | 218166 | 4.51 |
03:38 ET | 92162 | 4.515 |
03:39 ET | 56189 | 4.515 |
03:41 ET | 68788 | 4.525 |
03:43 ET | 103821 | 4.535 |
03:45 ET | 123558 | 4.555 |
03:48 ET | 241227 | 4.58 |
03:50 ET | 176808 | 4.585 |
03:52 ET | 671718 | 4.615 |
03:54 ET | 277718 | 4.605 |
03:56 ET | 522141 | 4.64 |
03:57 ET | 246658 | 4.645 |
03:59 ET | 14771536 | 4.65 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.8B | -13.4x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.0x | --- |
Structure Therapeutics Inc | 2.6B | -19.6x | --- |
IDEAYA Biosciences Inc | 2.8B | -18.5x | --- |
Biohaven Ltd | 3.0B | -4.9x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 5,304.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.